BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19400993)

  • 21. Sequential low-dose step-up and step-down protocols with recombinant follicle-stimulating hormone in polycystic ovary syndrome: prospective comparison with step-down protocol.
    Casadei L; Puca F; Emidi E; Manicuti C; Madrigale A; Piccione E
    Arch Gynecol Obstet; 2012 Nov; 286(5):1291-7. PubMed ID: 22729136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.
    Weiss NS; Nahuis M; Bayram N; Mol BW; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2015 Sep; (9):CD010290. PubMed ID: 26350625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements.
    Homburg R; Howles CM
    Hum Reprod Update; 1999; 5(5):493-9. PubMed ID: 10582786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vivo ovarian androgen responses to recombinant FSH with and without recombinant LH in polycystic ovarian syndrome.
    Cheung AP; Pride SM; Yuen BH; Sy L
    Hum Reprod; 2002 Oct; 17(10):2540-7. PubMed ID: 12351525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome.
    Hugues JN; Cédrin-Durnerin I; Avril C; Bulwa S; Hervé F; Uzan M
    Hum Reprod; 1996 Dec; 11(12):2581-4. PubMed ID: 9021354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy.
    Orvieto R; Homburg R
    Fertil Steril; 2009 Apr; 91(4 Suppl):1533-5. PubMed ID: 18990384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary syndrome patients: a prospective randomized analysis of cost-effectiveness.
    Gerli S; Casini ML; Unfer V; Costabile L; Mignosa M; Di Renzo GC
    Reprod Biomed Online; 2004 Nov; 9(5):494-9. PubMed ID: 15588465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.
    van Santbrink EJ; Fauser BC
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new look at low-dose aspirin: Co-administration with tamoxifen in ovulation induction in anovulatory PCOS women.
    Aref NK; Ahmed WAS; Ahmed MR; Sedik WF
    J Gynecol Obstet Hum Reprod; 2019 Oct; 48(8):673-675. PubMed ID: 30807853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH-preparations.
    Strowitzki T; Seehaus D; Korell M; Hepp H
    Exp Clin Endocrinol Diabetes; 1998; 106(5):435-9. PubMed ID: 9831312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility.
    Balen AH; Platteau P; Andersen AN; Devroey P; Sørensen P; Helmgaard L; Arce JC
    BJOG; 2006 Oct; 113(10):1195-202. PubMed ID: 16903840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome: a systematic review based on a Cochrane review.
    van Wely M; Bayram N; van der Veen F
    Hum Reprod; 2003 Jun; 18(6):1143-9. PubMed ID: 12773438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome.
    Christin-Maitre S; Hugues JN;
    Hum Reprod; 2003 Aug; 18(8):1626-31. PubMed ID: 12871872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovulation induction and controlled ovarian stimulation using letrozole gonadotropin combination: A single center retrospective cohort study.
    Arya S; Kupesic-Plavsic S; Mulla ZD; Dwivedi AK; Crisp Z; Jose J; Noble LS
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():123-128. PubMed ID: 28985546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human luteinizing hormone to trigger ovulation: randomized, controlled, dose-finding pilot study in ovulation induction.
    Pierson RA; Olatunbosun OA; Chizen DR; Saunders H; Loumaye E; De Moustier B
    J Reprod Med; 2014; 59(7-8):355-66. PubMed ID: 25098025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of luteal phase support on gonadotropin ovulation induction cycles in patients with polycystic ovary syndrome.
    Yazici G; Savas A; Tasdelen B; Dilek S
    J Reprod Med; 2014; 59(1-2):25-30. PubMed ID: 24597283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of anovulatory infertility associated with polycystic ovary syndrome: tamoxifen citrate an effective alternative compound to clomiphene citrate.
    Nardo LG
    Gynecol Endocrinol; 2004 Nov; 19(5):235-8. PubMed ID: 15726910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility.
    Mulders AG; Eijkemans MJ; Imani B; Fauser BC
    Reprod Biomed Online; 2003 Sep; 7(2):170-8. PubMed ID: 14567885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
    Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.